A Double-Blinded, Randomized, Controlled Study to Compare the Efficacy, Time to Onset, and Duration of Effect of Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines
Latest Information Update: 21 Mar 2025
At a glance
- Drugs Botulinum-Toxin-A (Primary) ; Letibotulinumtoxina (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Acronyms H2H
- Sponsors Croma Pharma
Most Recent Events
- 19 Feb 2021 Status changed from recruiting to completed.
- 27 Mar 2020 New trial record